(Z)-3-(4-(1-(4-chlorophenyl)-1H-1,2,3-triazol-4-yl)benzylidene)indolin-2-one

ID: ALA4872149

PubChem CID: 149735519

Max Phase: Preclinical

Molecular Formula: C23H15ClN4O

Molecular Weight: 398.85

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C1Nc2ccccc2/C1=C/c1ccc(-c2cn(-c3ccc(Cl)cc3)nn2)cc1

Standard InChI:  InChI=1S/C23H15ClN4O/c24-17-9-11-18(12-10-17)28-14-22(26-27-28)16-7-5-15(6-8-16)13-20-19-3-1-2-4-21(19)25-23(20)29/h1-14H,(H,25,29)/b20-13-

Standard InChI Key:  BABVBOGFVAJRAX-MOSHPQCFSA-N

Molfile:  

 
     RDKit          2D

 29 33  0  0  0  0  0  0  0  0999 V2000
    2.1530  -24.1195    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1519  -24.9390    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8599  -25.3480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8581  -23.7106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5667  -24.1159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5716  -24.9390    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3559  -25.1889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8359  -24.5200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3481  -23.8570    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6130  -25.9646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4133  -26.1298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6531  -24.5152    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6656  -26.9079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4651  -27.0733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0093  -26.4625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7484  -25.6836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9495  -25.5218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8112  -26.6247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1489  -27.3688    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.9610  -27.2776    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.1252  -26.4770    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.4145  -26.0736    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8666  -26.1404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5313  -26.6177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2749  -26.2805    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3549  -25.4664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6854  -24.9905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9445  -25.3303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0986  -25.1276    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  5  1  0
  7 10  2  0
 10 11  1  0
  8 12  2  0
 11 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 11  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 18  2  0
 15 18  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 21 23  1  0
 26 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4872149

    ---

Associated Targets(Human)

KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MKN-45 (2102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HUVEC (11049 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 398.85Molecular Weight (Monoisotopic): 398.0934AlogP: 5.08#Rotatable Bonds: 3
Polar Surface Area: 59.81Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.31CX Basic pKa: CX LogP: 5.61CX LogD: 5.61
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.49Np Likeness Score: -1.35

References

1. Wang DP, Liu KL, Li XY, Lu GQ, Xue WH, Qian XH, Mohamed O K, Meng FH..  (2021)  Design, synthesis, and in vitro and in vivo anti-angiogenesis study of a novel vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor based on 1,2,3-triazole scaffold.,  211  [PMID:33340911] [10.1016/j.ejmech.2020.113083]

Source